Global Intranasal Vaccine Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intranasal Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
By Company
- Sanofi
- AstraZeneca
- Abbott
- GlaxoSmithKline
- Serum Institute of India
- Bharat Biotech
- Antares Pharma
- INJEX Pharma GmbH
- BioDiem
- PharmaJet and Crossject
- Beijing Wantai Biopharmaceutical Co., Ltd.
- Flu Vaccine
- COVID-19 Vaccines
- Hospital
- Clinic
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 INTRANASAL VACCINE MARKET OVERVIEW
1.1 Product Overview and Scope of Intranasal Vaccine
1.2 Intranasal Vaccine Segment by Type
1.2.1 Global Intranasal Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Flu Vaccine
1.2.3 COVID-19 Vaccines
1.3 Intranasal Vaccine Segment by Application
1.3.1 Global Intranasal Vaccine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Intranasal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Intranasal Vaccine Revenue 2018-2029
1.4.2 Global Intranasal Vaccine Sales 2018-2029
1.4.3 Global Intranasal Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INTRANASAL VACCINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Intranasal Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intranasal Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intranasal Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Intranasal Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intranasal Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Vaccine, Product Type & Application
2.7 Intranasal Vaccine Market Competitive Situation and Trends
2.7.1 Intranasal Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intranasal Vaccine Players Market Share by Revenue
2.7.3 Global Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INTRANASAL VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Intranasal Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intranasal Vaccine Global Intranasal Vaccine Sales by Region: 2018-2029
3.2.1 Global Intranasal Vaccine Sales by Region: 2018-2023
3.2.2 Global Intranasal Vaccine Sales by Region: 2024-2029
3.3 Global Intranasal Vaccine Global Intranasal Vaccine Revenue by Region: 2018-2029
3.3.1 Global Intranasal Vaccine Revenue by Region: 2018-2023
3.3.2 Global Intranasal Vaccine Revenue by Region: 2024-2029
3.4 North America Intranasal Vaccine Market Facts & Figures by Country
3.4.1 North America Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intranasal Vaccine Sales by Country (2018-2029)
3.4.3 North America Intranasal Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intranasal Vaccine Market Facts & Figures by Country
3.5.1 Europe Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intranasal Vaccine Sales by Country (2018-2029)
3.5.3 Europe Intranasal Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intranasal Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Intranasal Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intranasal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intranasal Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Intranasal Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intranasal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intranasal Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intranasal Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Intranasal Vaccine Sales by Type (2018-2029)
4.1.1 Global Intranasal Vaccine Sales by Type (2018-2023)
4.1.2 Global Intranasal Vaccine Sales by Type (2024-2029)
4.1.3 Global Intranasal Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Intranasal Vaccine Revenue by Type (2018-2029)
4.2.1 Global Intranasal Vaccine Revenue by Type (2018-2023)
4.2.2 Global Intranasal Vaccine Revenue by Type (2024-2029)
4.2.3 Global Intranasal Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Intranasal Vaccine Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Intranasal Vaccine Sales by Application (2018-2029)
5.1.1 Global Intranasal Vaccine Sales by Application (2018-2023)
5.1.2 Global Intranasal Vaccine Sales by Application (2024-2029)
5.1.3 Global Intranasal Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Intranasal Vaccine Revenue by Application (2018-2029)
5.2.1 Global Intranasal Vaccine Revenue by Application (2018-2023)
5.2.2 Global Intranasal Vaccine Revenue by Application (2024-2029)
5.2.3 Global Intranasal Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Intranasal Vaccine Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Intranasal Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Intranasal Vaccine Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Intranasal Vaccine Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline Intranasal Vaccine Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute of India Intranasal Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bharat Biotech Intranasal Vaccine Product Portfolio
6.6.5 Bharat Biotech Recent Developments/Updates
6.7 Antares Pharma
6.6.1 Antares Pharma Corporation Information
6.6.2 Antares Pharma Description and Business Overview
6.6.3 Antares Pharma Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Antares Pharma Intranasal Vaccine Product Portfolio
6.7.5 Antares Pharma Recent Developments/Updates
6.8 INJEX Pharma GmbH
6.8.1 INJEX Pharma GmbH Corporation Information
6.8.2 INJEX Pharma GmbH Description and Business Overview
6.8.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 INJEX Pharma GmbH Intranasal Vaccine Product Portfolio
6.8.5 INJEX Pharma GmbH Recent Developments/Updates
6.9 BioDiem
6.9.1 BioDiem Corporation Information
6.9.2 BioDiem Description and Business Overview
6.9.3 BioDiem Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BioDiem Intranasal Vaccine Product Portfolio
6.9.5 BioDiem Recent Developments/Updates
6.10 PharmaJet and Crossject
6.10.1 PharmaJet and Crossject Corporation Information
6.10.2 PharmaJet and Crossject Description and Business Overview
6.10.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 PharmaJet and Crossject Intranasal Vaccine Product Portfolio
6.10.5 PharmaJet and Crossject Recent Developments/Updates
6.11 Beijing Wantai Biopharmaceutical Co., Ltd.
6.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Corporation Information
6.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Description and Business Overview
6.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio
6.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Intranasal Vaccine Industry Chain Analysis
7.2 Intranasal Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Vaccine Production Mode & Process
7.4 Intranasal Vaccine Sales and Marketing
7.4.1 Intranasal Vaccine Sales Channels
7.4.2 Intranasal Vaccine Distributors
7.5 Intranasal Vaccine Customers
8 INTRANASAL VACCINE MARKET DYNAMICS
8.1 Intranasal Vaccine Industry Trends
8.2 Intranasal Vaccine Market Drivers
8.3 Intranasal Vaccine Market Challenges
8.4 Intranasal Vaccine Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Intranasal Vaccine
1.2 Intranasal Vaccine Segment by Type
1.2.1 Global Intranasal Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Flu Vaccine
1.2.3 COVID-19 Vaccines
1.3 Intranasal Vaccine Segment by Application
1.3.1 Global Intranasal Vaccine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Intranasal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Intranasal Vaccine Revenue 2018-2029
1.4.2 Global Intranasal Vaccine Sales 2018-2029
1.4.3 Global Intranasal Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INTRANASAL VACCINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Intranasal Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intranasal Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intranasal Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Intranasal Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intranasal Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Vaccine, Product Type & Application
2.7 Intranasal Vaccine Market Competitive Situation and Trends
2.7.1 Intranasal Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intranasal Vaccine Players Market Share by Revenue
2.7.3 Global Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INTRANASAL VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Intranasal Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intranasal Vaccine Global Intranasal Vaccine Sales by Region: 2018-2029
3.2.1 Global Intranasal Vaccine Sales by Region: 2018-2023
3.2.2 Global Intranasal Vaccine Sales by Region: 2024-2029
3.3 Global Intranasal Vaccine Global Intranasal Vaccine Revenue by Region: 2018-2029
3.3.1 Global Intranasal Vaccine Revenue by Region: 2018-2023
3.3.2 Global Intranasal Vaccine Revenue by Region: 2024-2029
3.4 North America Intranasal Vaccine Market Facts & Figures by Country
3.4.1 North America Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intranasal Vaccine Sales by Country (2018-2029)
3.4.3 North America Intranasal Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intranasal Vaccine Market Facts & Figures by Country
3.5.1 Europe Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intranasal Vaccine Sales by Country (2018-2029)
3.5.3 Europe Intranasal Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intranasal Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Intranasal Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intranasal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intranasal Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Intranasal Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intranasal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intranasal Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intranasal Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Intranasal Vaccine Sales by Type (2018-2029)
4.1.1 Global Intranasal Vaccine Sales by Type (2018-2023)
4.1.2 Global Intranasal Vaccine Sales by Type (2024-2029)
4.1.3 Global Intranasal Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Intranasal Vaccine Revenue by Type (2018-2029)
4.2.1 Global Intranasal Vaccine Revenue by Type (2018-2023)
4.2.2 Global Intranasal Vaccine Revenue by Type (2024-2029)
4.2.3 Global Intranasal Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Intranasal Vaccine Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Intranasal Vaccine Sales by Application (2018-2029)
5.1.1 Global Intranasal Vaccine Sales by Application (2018-2023)
5.1.2 Global Intranasal Vaccine Sales by Application (2024-2029)
5.1.3 Global Intranasal Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Intranasal Vaccine Revenue by Application (2018-2029)
5.2.1 Global Intranasal Vaccine Revenue by Application (2018-2023)
5.2.2 Global Intranasal Vaccine Revenue by Application (2024-2029)
5.2.3 Global Intranasal Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Intranasal Vaccine Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Intranasal Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Intranasal Vaccine Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Intranasal Vaccine Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline Intranasal Vaccine Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute of India Intranasal Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bharat Biotech Intranasal Vaccine Product Portfolio
6.6.5 Bharat Biotech Recent Developments/Updates
6.7 Antares Pharma
6.6.1 Antares Pharma Corporation Information
6.6.2 Antares Pharma Description and Business Overview
6.6.3 Antares Pharma Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Antares Pharma Intranasal Vaccine Product Portfolio
6.7.5 Antares Pharma Recent Developments/Updates
6.8 INJEX Pharma GmbH
6.8.1 INJEX Pharma GmbH Corporation Information
6.8.2 INJEX Pharma GmbH Description and Business Overview
6.8.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 INJEX Pharma GmbH Intranasal Vaccine Product Portfolio
6.8.5 INJEX Pharma GmbH Recent Developments/Updates
6.9 BioDiem
6.9.1 BioDiem Corporation Information
6.9.2 BioDiem Description and Business Overview
6.9.3 BioDiem Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BioDiem Intranasal Vaccine Product Portfolio
6.9.5 BioDiem Recent Developments/Updates
6.10 PharmaJet and Crossject
6.10.1 PharmaJet and Crossject Corporation Information
6.10.2 PharmaJet and Crossject Description and Business Overview
6.10.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 PharmaJet and Crossject Intranasal Vaccine Product Portfolio
6.10.5 PharmaJet and Crossject Recent Developments/Updates
6.11 Beijing Wantai Biopharmaceutical Co., Ltd.
6.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Corporation Information
6.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Description and Business Overview
6.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio
6.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Intranasal Vaccine Industry Chain Analysis
7.2 Intranasal Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Vaccine Production Mode & Process
7.4 Intranasal Vaccine Sales and Marketing
7.4.1 Intranasal Vaccine Sales Channels
7.4.2 Intranasal Vaccine Distributors
7.5 Intranasal Vaccine Customers
8 INTRANASAL VACCINE MARKET DYNAMICS
8.1 Intranasal Vaccine Industry Trends
8.2 Intranasal Vaccine Market Drivers
8.3 Intranasal Vaccine Market Challenges
8.4 Intranasal Vaccine Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Intranasal Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Intranasal Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Intranasal Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Intranasal Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Intranasal Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Intranasal Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Intranasal Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Intranasal Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Intranasal Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Intranasal Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intranasal Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Intranasal Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intranasal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intranasal Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Intranasal Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Intranasal Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Intranasal Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Intranasal Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Intranasal Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Intranasal Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Intranasal Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Intranasal Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Intranasal Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Intranasal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Intranasal Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Intranasal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Intranasal Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Intranasal Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Intranasal Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Intranasal Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Intranasal Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Intranasal Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Intranasal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Intranasal Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Intranasal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Intranasal Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Intranasal Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Intranasal Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Intranasal Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Intranasal Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Intranasal Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Intranasal Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Intranasal Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Intranasal Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Intranasal Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Intranasal Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Intranasal Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Intranasal Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Intranasal Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Intranasal Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Intranasal Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Intranasal Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Intranasal Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Intranasal Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Intranasal Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Sanofi Intranasal Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. AstraZeneca Intranasal Vaccine Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Intranasal Vaccine Product
Table 84. Abbott Recent Developments/Updates
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GlaxoSmithKline Intranasal Vaccine Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Serum Institute of India Intranasal Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Bharat Biotech Corporation Information
Table 96. Bharat Biotech Description and Business Overview
Table 97. Bharat Biotech Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Bharat Biotech Intranasal Vaccine Product
Table 99. Bharat Biotech Recent Developments/Updates
Table 100. Antares Pharma Corporation Information
Table 101. Antares Pharma Description and Business Overview
Table 102. Antares Pharma Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Antares Pharma Intranasal Vaccine Product
Table 104. Antares Pharma Recent Developments/Updates
Table 105. INJEX Pharma GmbH Corporation Information
Table 106. INJEX Pharma GmbH Description and Business Overview
Table 107. INJEX Pharma GmbH Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. INJEX Pharma GmbH Intranasal Vaccine Product
Table 109. INJEX Pharma GmbH Recent Developments/Updates
Table 110. BioDiem Corporation Information
Table 111. BioDiem Description and Business Overview
Table 112. BioDiem Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. BioDiem Intranasal Vaccine Product
Table 114. BioDiem Recent Developments/Updates
Table 115. PharmaJet and Crossject Corporation Information
Table 116. PharmaJet and Crossject Description and Business Overview
Table 117. PharmaJet and Crossject Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. PharmaJet and Crossject Intranasal Vaccine Product
Table 119. PharmaJet and Crossject Recent Developments/Updates
Table 120. Beijing Wantai Biopharmaceutical Co., Ltd. Corporation Information
Table 121. Beijing Wantai Biopharmaceutical Co., Ltd. Description and Business Overview
Table 122. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product
Table 124. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Intranasal Vaccine Distributors List
Table 128. Intranasal Vaccine Customers List
Table 129. Intranasal Vaccine Market Trends
Table 130. Intranasal Vaccine Market Drivers
Table 131. Intranasal Vaccine Market Challenges
Table 132. Intranasal Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 1. Global Intranasal Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Intranasal Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Intranasal Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Intranasal Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Intranasal Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Intranasal Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Intranasal Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Intranasal Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Intranasal Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Intranasal Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intranasal Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Intranasal Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intranasal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intranasal Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Intranasal Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Intranasal Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Intranasal Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Intranasal Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Intranasal Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Intranasal Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Intranasal Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Intranasal Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Intranasal Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Intranasal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Intranasal Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Intranasal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Intranasal Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Intranasal Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Intranasal Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Intranasal Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Intranasal Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Intranasal Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Intranasal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Intranasal Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Intranasal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Intranasal Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Intranasal Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Intranasal Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Intranasal Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Intranasal Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Intranasal Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Intranasal Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Intranasal Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Intranasal Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Intranasal Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Intranasal Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Intranasal Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Intranasal Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Intranasal Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Intranasal Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Intranasal Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Intranasal Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Intranasal Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Intranasal Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Intranasal Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Sanofi Intranasal Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. AstraZeneca Intranasal Vaccine Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Intranasal Vaccine Product
Table 84. Abbott Recent Developments/Updates
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GlaxoSmithKline Intranasal Vaccine Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Serum Institute of India Intranasal Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Bharat Biotech Corporation Information
Table 96. Bharat Biotech Description and Business Overview
Table 97. Bharat Biotech Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Bharat Biotech Intranasal Vaccine Product
Table 99. Bharat Biotech Recent Developments/Updates
Table 100. Antares Pharma Corporation Information
Table 101. Antares Pharma Description and Business Overview
Table 102. Antares Pharma Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Antares Pharma Intranasal Vaccine Product
Table 104. Antares Pharma Recent Developments/Updates
Table 105. INJEX Pharma GmbH Corporation Information
Table 106. INJEX Pharma GmbH Description and Business Overview
Table 107. INJEX Pharma GmbH Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. INJEX Pharma GmbH Intranasal Vaccine Product
Table 109. INJEX Pharma GmbH Recent Developments/Updates
Table 110. BioDiem Corporation Information
Table 111. BioDiem Description and Business Overview
Table 112. BioDiem Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. BioDiem Intranasal Vaccine Product
Table 114. BioDiem Recent Developments/Updates
Table 115. PharmaJet and Crossject Corporation Information
Table 116. PharmaJet and Crossject Description and Business Overview
Table 117. PharmaJet and Crossject Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. PharmaJet and Crossject Intranasal Vaccine Product
Table 119. PharmaJet and Crossject Recent Developments/Updates
Table 120. Beijing Wantai Biopharmaceutical Co., Ltd. Corporation Information
Table 121. Beijing Wantai Biopharmaceutical Co., Ltd. Description and Business Overview
Table 122. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product
Table 124. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Intranasal Vaccine Distributors List
Table 128. Intranasal Vaccine Customers List
Table 129. Intranasal Vaccine Market Trends
Table 130. Intranasal Vaccine Market Drivers
Table 131. Intranasal Vaccine Market Challenges
Table 132. Intranasal Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Intranasal Vaccine
Figure 2. Global Intranasal Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Intranasal Vaccine Market Share by Type in 2022 & 2029
Figure 4. Flu Vaccine Product Picture
Figure 5. COVID-19 Vaccines Product Picture
Figure 6. Global Intranasal Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Intranasal Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Intranasal Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Intranasal Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Intranasal Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Intranasal Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Intranasal Vaccine Report Years Considered
Figure 15. Intranasal Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Intranasal Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Intranasal Vaccine Players: Market Share by Revenue in 2022
Figure 18. Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Intranasal Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Intranasal Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Intranasal Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Intranasal Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Intranasal Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Intranasal Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Intranasal Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Intranasal Vaccine Sales Market Share by Country (2018-2029)
Figure 41. Latin America Intranasal Vaccine Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Colombia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Intranasal Vaccine Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Intranasal Vaccine Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Intranasal Vaccine by Type (2018-2029)
Figure 52. Global Revenue Market Share of Intranasal Vaccine by Type (2018-2029)
Figure 53. Global Intranasal Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Intranasal Vaccine by Application (2018-2029)
Figure 55. Global Revenue Market Share of Intranasal Vaccine by Application (2018-2029)
Figure 56. Global Intranasal Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 57. Intranasal Vaccine Value Chain
Figure 58. Intranasal Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Figure 1. Product Picture of Intranasal Vaccine
Figure 2. Global Intranasal Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Intranasal Vaccine Market Share by Type in 2022 & 2029
Figure 4. Flu Vaccine Product Picture
Figure 5. COVID-19 Vaccines Product Picture
Figure 6. Global Intranasal Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Intranasal Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Intranasal Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Intranasal Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Intranasal Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Intranasal Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Intranasal Vaccine Report Years Considered
Figure 15. Intranasal Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Intranasal Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Intranasal Vaccine Players: Market Share by Revenue in 2022
Figure 18. Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Intranasal Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Intranasal Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Intranasal Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Intranasal Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Intranasal Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Intranasal Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Intranasal Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Intranasal Vaccine Sales Market Share by Country (2018-2029)
Figure 41. Latin America Intranasal Vaccine Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Colombia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Intranasal Vaccine Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Intranasal Vaccine Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Intranasal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Intranasal Vaccine by Type (2018-2029)
Figure 52. Global Revenue Market Share of Intranasal Vaccine by Type (2018-2029)
Figure 53. Global Intranasal Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Intranasal Vaccine by Application (2018-2029)
Figure 55. Global Revenue Market Share of Intranasal Vaccine by Application (2018-2029)
Figure 56. Global Intranasal Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 57. Intranasal Vaccine Value Chain
Figure 58. Intranasal Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
